Treatment Exemestane Aromasin Powder kitty@yuancheAd id : 2743
Price : Please contact
Date listed : 2018-Jan-10


Breast Cancer Treatment Exemestane Aromasin Powder kitty@yuanchengtech.com

Name:Exemestane 
CAS NO.:107868-30-4
Chemical Name: 6-Methylenandrosta-1,4-diene-3,17-dione
Molecular Formula: C20H24O2
Molecular weight: 296.40
Assay: 99%
Appearance: white to almost white powder

Application:
Exemestane (Aromasin) is a drug used to treat breast cancer. 
It is a member of the class of drugs known as aromatase inhibitors. Some breast cancers require estrogen to grow. Those cancers have estrogen receptors (ERs), and are called ER-positive. They may also be called estrogen-responsive, hormonally-responsive, or hormone-receptor-positive. Aromatase is an enzyme that synthesizes estrogen. Aromatase inhibitors block the synthesis of estrogen. This lowers the estrogen level, and slows the growth of cancers.

Contact:
Skype:kitty chen
kitty@yuanchengtech.com
WhatsApp:86 18029247504






Contact poster by email
Your email


Your name


Your message (how to avoid scammers?)


Verification






How to avoid scams and fraud

You are about to contact the poster. To avoid scammers please follow these common-sense rules:

1/ Deal locally with people you can meet in person.

2/ Never wire funds via Western union or any other wire service.

3/ Saudi Free Classifieds - No registration needed. Absolutely free! is not involved in any transaction, and does not handle payments, guarantee transactions, or offer "buyer protection" or "seller certification".

4/ Never give out financial information (bank account number, social security number, eBay/PayPal info, etc.)

5/ Avoid deals involving shipping or escrow services.


Close



advanced search


Search forexact phrase
Category
Area
Zip Code
Price SAR to
With Photo

Help | About | Privacy Policy | Contact Saudi Free Classifieds - No registration needed. Absolutely free! | Copyright 2013 MeFlair.com
Sitemap Generator

MEFlair.com is a part of Voyager IT Solutions, a unit of MBA Fakhro Holding.